featured
Development and Validation of a Prediction Score for HCC Recurrence Risk After Liver Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Liver Transplantation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Liver Transpl. 2023 Jul 01;29(7)683-697, BV Tran, D Moris, D Markovic, H Zaribafzadeh, R Henao, Q Lai, SS Florman, P Tabrizian, B Haydel, RM Ruiz, GB Klintmalm, DD Lee, CB Taner, M Hoteit, MH Levine, U Cillo, A Vitale, EC Verna, KJ Halazun, AD Tevar, A Humar, WC Chapman, N Vachharajani, F Aucejo, J Lerut, O Ciccarelli, MH Nguyen, ML Melcher, A Viveiros, B Schaefer, M Hoppe-Lotichius, J Mittler, TL Nydam, JF Markmann, M Rossi, C Mobley, M Ghobrial, AN Langnas, CA Carney, J Berumen, GT Schnickel, DL Sudan, JC Hong, A Rana, CM Jones, TM Fishbein, RW Busuttil, AS Barbas, VG AgopianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.